10/10/2023 Argaam Exclusive
AI Summary
Shares of Nahdi Medical Co. dropped 2% to close at SAR 137.20, the lowest since debut on the main market (TASI), with nearly 436,000 shares traded.
| Year High (SAR) | Year Low (SAR) |
| 209.20 | 137.20 |
| Highest Since Debut (SAR) | Lowest Since Debut (SAR) |
| 209.40 | 137.20 |
Thus, the stock's year-to-date (YTD) losses reached 16% and 12-month losses hit almost 30%.
| Open | 105.00 |
| Low | 102.40 |
| High | 105.50 |
| Previous Close | 105.00 |
| Change (3M) | 7.69 % |
| Change (6M) | (7.42 %) |
| Market Value | 13,468.00 |
| Avg. Volume (3M) | 212,228.13 |
| Avg. Turnover (3M) | 20,687,805.78 |
| Avg. Transaction (3M) | 2,193.98 |
| Change(12M) | (11.75 %) |
| YTD | 9.05 % |
The company did not carry out any changes to its capital since debut in 2022.
| Date | Type | Capital (M Riyal) | Change (%) |
| 2022 | IPO | 1,300.00 | 0.00% |
| Financial Ratio | Current |
| Market Cap (M Riyal) | 13,468.01 |
| Shares Outstanding ((M)) | 130.00 |
| EPS ( ) (TTM) | 6.39 |
| Book Value (BV) ( Riyal) (Latest announcement) | 21.10 |
| Recurring P/E | 16.57 |
| Price/book | 4.91 |
| Dividend Yield (%) (Last Year) | 5.41 |
| Return on Average Assets (%) (TTM) | 12.91 |
| Return on Average Equity (%) (TTM) | 31.17 |
| Par Value ( Riyal) | 10.00 |
| Enterprise Value (EV) (M Riyal) | 12,914.01 |
| EV/adj EBITDA | - |
| EV/Revenues | 1.26 |
Fair Average Price
Number of Recommendations
| Rating | Research firm | Current Price | Target Price | Change | |
| Neutral | Citi Bank Group | 157.00 | 180.00 | 14.65 % | |
| Buy | Riyad Capital | 175.40 | 214.00 | 22.01 % |
Be the first to comment
Comments Analysis: